COMPOUNDS FOR THE TREATMENT OF HIV INFECTION AND OTHER DISEASES CAUSED BY RNA VIRUSES
Patent number:
US2021267981
ES2736260
No items found.
Use of organic compounds for the treatment of the infection caused by human immunodeficiency virus type 1 (HIV-1), as well as other diseases caused by RNA viruses is disclosed.
Countries:
Spain
Regions:
Valencian Community
Centers:
UNIVERSIDAD CATOLICA DE VALENCIA SAN VICENTE MARTIR, INSTITUTO DE SALUD CARLOS III
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals, Organic fine chemistry, Y02A50/30
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
The compounds it protects have activity against the HIV-1 virus using an alternative mechanism of action not used by current antiretrovirals, based on inhibition of viral RNA biogenesis and blocking the function of the viral protein Rev
Comments
Other related patents
Health
USE OF PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES
Food & Agro
New & Sustainable Materials
Health
SYSTEM AND METHOD FOR GENERATING MONODISPERSE MICROBUBBLES IN A CO-FLOW CONFIGURATION
Health



.jpg)